
Why a standard panel is not always enough
A standard lipid panel reports total cholesterol, LDL, HDL and triglycerides. It works well for many people, but it can underestimate risk in some groups: people with high triglycerides, diabetes or metabolic syndrome, people with a strong family history of early heart disease, and people who have inherited high lipoprotein(a), which a standard panel does not measure.
Additional tests help most when your risk is borderline or intermediate, or when your family history does not fit your numbers.
ApoB: counting particles
Each cholesterol-carrying particle that can enter the artery wall carries one apolipoprotein B molecule, so ApoB is a count of potentially harmful particles. When LDL and ApoB disagree, which is more common with high triglycerides or insulin resistance, ApoB may better reflect risk. The 2018 AHA/ACC guideline lists an ApoB of 130 mg/dL or higher as a risk-enhancing factor, and the 2026 ACC/AHA guideline is the first U.S. guideline to include ApoB for selected people.
Lipoprotein(a): the inherited factor
Lipoprotein(a) is an LDL-like particle whose level is mainly set by genes. A high level raises the risk of heart attack, stroke and aortic valve narrowing, and lifestyle changes do little to lower it. The 2018 guideline treats 50 mg/dL or higher, or 125 nmol/L or higher, as a risk enhancer, and the 2026 ACC/AHA guideline recommends measuring it at least once in all adults.
A high result does not mean a heart attack is coming. It means other risk factors, especially LDL and blood pressure, deserve closer attention, and relatives may want to be tested.
hs-CRP: a window on inflammation
High-sensitivity C-reactive protein measures low-grade inflammation. A level of 2.0 mg/L or higher is a risk-enhancing factor in the 2018 guideline. It is non-specific, though: a cold, an injury or a hard workout can raise it temporarily, so an elevated value is usually repeated when you are well.
Coronary artery calcium score
A calcium score uses a low-dose CT scan of the heart to measure calcified plaque in the coronary arteries. A score of zero in a person at borderline or intermediate risk can support delaying a statin, while a higher score strengthens the case for treatment. Under the 2026 guideline summary, any non-zero score signals that plaque is present and shapes treatment intensity.
The test involves some radiation, can find incidental lung findings that lead to more scans, and adds little for people already on statins. The USPSTF found insufficient evidence to recommend it for everyone.
What the guidelines say, side by side
Professional cardiology guidelines and the USPSTF approach these tests differently. Cardiology guidelines use them to refine individual decisions, while the USPSTF asks whether screening entire populations improves outcomes. Both perspectives are reasonable, which is why the best answer for you depends on your current risk and what decision is on the table.
Who benefits most from extra testing
Extra heart tests are most likely to change management in a few groups. People whose estimated 10-year risk falls in the borderline or intermediate range may be moved up or down by an Lp(a), ApoB or calcium score result. People with a family history of early heart disease may have an inherited problem a standard panel misses. And people with diabetes, high triglycerides or metabolic syndrome often have more particles than their LDL suggests.
By contrast, someone already on a statin with well-controlled LDL, or someone at clearly low risk, may gain little. Women should also know that early menopause and pregnancy complications such as preeclampsia are recognized risk enhancers in the 2018 guideline, which can tip the balance toward testing or treatment.
Do not forget the basics
None of these tests replaces knowing your blood pressure, smoking status, blood sugar and family history. For many people, the most powerful heart test is a week of validated home blood pressure readings.
Questions to ask
- What is my estimated 10-year cardiovascular risk?
- Would ApoB or a calcium score change what we do?
- Have I had lipoprotein(a) tested, and should my relatives?
- If my hs-CRP is high, should we repeat it when I am well?
- What LDL or ApoB target makes sense for me?
Testing through HealifyMD
A licensed HealifyMD clinician can order lipid testing and advanced markers where they would change a decision, and review the results with you. Labs are priced separately and confirmed during your eligibility review.
| Test | What it measures | Most useful when | Guideline note |
|---|---|---|---|
| ApoB | Number of atherogenic particles | High triglycerides, diabetes, borderline risk | Risk enhancer at 130 mg/dL or higher (2018) |
| Lipoprotein(a) | Inherited LDL-like particle | Everyone, once; family history of early heart disease | Measure once in all adults (2026) |
| hs-CRP | Low-grade inflammation | Borderline or intermediate risk | Risk enhancer at 2.0 mg/L or higher (2018); USPSTF: insufficient evidence for routine use |
| Calcium score | Calcified coronary plaque | Uncertain statin decision, often over 40 to 55 | USPSTF: insufficient evidence for routine screening |
Common questions
Should everyone get lipoprotein(a) tested?
The 2026 ACC/AHA dyslipidemia guideline recommends measuring it at least once in all adults, since it is mostly inherited and not captured by standard panels.
Is ApoB better than LDL?
They usually agree. ApoB adds most when they diverge, such as with high triglycerides, diabetes or metabolic syndrome.
Does a calcium score of zero mean I am safe?
It suggests low near-term risk, but soft plaque does not show on a calcium scan and risk factors still need managing.
Can I lower my lipoprotein(a) with diet?
Lifestyle has little effect on Lp(a). Management focuses on lowering LDL and controlling other risk factors.
Why might my hs-CRP be high?
A recent cold, injury, hard exercise or chronic inflammatory conditions can raise it. It is usually repeated when you are well.
Is a calcium scan safe?
It uses a low dose of radiation and is generally safe, but it can reveal incidental findings that lead to more tests.
Sources
We cite government agencies, professional societies and peer-reviewed research. See our editorial policy.
- 2018 Guideline on the Management of Blood CholesterolAmerican Heart Association / American College of Cardiology
- Behind the guidelines: top clinical takeaways from the 2026 dyslipidemia guidelinesHCPLive
- Cardiovascular Disease: Risk Assessment With Nontraditional Risk FactorsU.S. Preventive Services Task Force
- Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive MedicationU.S. Preventive Services Task Force
- Monitoring your blood pressure at homeAmerican Heart Association